Regeneron Pharmaceuticals Long Term Debt 2006-2019 | REGN

Regeneron Pharmaceuticals long term debt from 2006 to 2019. Long term debt can be defined as the sum of all long term debt fields.
  • Regeneron Pharmaceuticals long term debt for the quarter ending December 31, 2019 was $0.714B, a 0.76% increase year-over-year.
  • Regeneron Pharmaceuticals long term debt for 2019 was $0.714B, a 0.76% increase from 2018.
  • Regeneron Pharmaceuticals long term debt for 2018 was $0.709B, a 0.71% increase from 2017.
  • Regeneron Pharmaceuticals long term debt for 2017 was $0.704B, a 100.1% increase from 2016.
Regeneron Pharmaceuticals Annual Long Term Debt
(Millions of US $)
2019 $714
2018 $709
2017 $704
2016 $352
2015 $363
2014 $458
2013 $505
2012 $456
2011 $435
2010 $159
2009 $109
2008 $54
2007 $
2006 $200
2005 $200
Regeneron Pharmaceuticals Quarterly Long Term Debt
(Millions of US $)
Q4 2019 $714
Q3 2019 $713
Q2 2019 $711
Q1 2019 $710
Q4 2018 $709
Q3 2018 $707
Q2 2018 $706
Q1 2018 $705
Q4 2017 $704
Q3 2017 $702
Q2 2017 $701
Q1 2017 $700
Q4 2016 $352
Q3 2016 $382
Q2 2016 $362
Q1 2016 $362
Q4 2015 $363
Q3 2015 $395
Q2 2015 $388
Q1 2015 $472
Q4 2014 $458
Q3 2014 $564
Q2 2014 $517
Q1 2014 $530
Q4 2013 $505
Q3 2013 $481
Q2 2013 $473
Q1 2013 $461
Q4 2012 $456
Q3 2012 $450
Q2 2012 $445
Q1 2012 $440
Q4 2011 $435
Q3 2011 $159
Q2 2011 $159
Q1 2011 $159
Q4 2010 $159
Q3 2010 $158
Q2 2010 $157
Q1 2010 $156
Q4 2009 $109
Q3 2009 $63
Q2 2009 $63
Q1 2009
Q4 2008 $54
Q3 2008
Q2 2008
Q1 2008
Q4 2007
Q3 2007 $200
Q2 2007 $200
Q1 2007 $200
Q4 2006 $200
Q3 2006 $200
Q2 2006 $200
Q1 2006 $200
Q4 2005 $200
Q3 2005 $200
Q2 2005 $200
Q1 2005 $200
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $46.799B $7.863B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.507B 14.69
CSL (CSLLY) Australia $95.284B 0.00
Gilead Sciences (GILD) United States $92.229B 11.87
Vertex Pharmaceuticals (VRTX) United States $61.449B 55.77
Biogen (BIIB) United States $56.741B 9.69
Illumina (ILMN) United States $41.325B 42.72
Alexion Pharmaceuticals (ALXN) United States $21.923B 10.20
Seattle Genetics (SGEN) United States $19.982B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Incyte (INCY) United States $17.097B 36.68
BioMarin Pharmaceutical (BMRN) United States $16.705B 0.00
Genmab (GNMSF) Denmark $15.114B 48.61
Exact Sciences (EXAS) United States $14.140B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.768B 0.00
Galapagos (GLPG) Belgium $13.461B 34.68
Bio-Rad Laboratories (BIO.B) United States $11.564B 54.03
BeiGene (BGNE) Cayman Islands $10.013B 0.00
Sarepta Therapeutics (SRPT) United States $8.913B 0.00
QIAGEN (QGEN) Netherlands $8.278B 25.49
Guardant Health (GH) United States $7.915B 0.00
Bio-Techne Corp (TECH) United States $7.732B 52.92
BioNTech SE (BNTX) Germany $6.924B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.508B 0.00
Ascendis Pharma (ASND) Denmark $6.484B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.462B 16.43
Amarin (AMRN) Ireland $6.280B 0.00
Moderna (MRNA) United States $6.256B 0.00
Exelixis (EXEL) United States $6.132B 17.25
ARGENX SE-ADR (ARGX) Netherlands $5.957B 0.00
Reata Pharmaceuticals (RETA) United States $5.940B 0.00
Repligen (RGEN) United States $4.826B 88.29
Acceleron Pharma (XLRN) United States $4.788B 0.00
China Biologic Products (CBPO) China $4.571B 25.75
Bluebird Bio (BLUE) United States $4.240B 0.00
Adaptive Biotechnologies (ADPT) United States $3.833B 0.00
MorphoSys AG (MOR) Germany $3.741B 0.00
Mirati Therapeutics (MRTX) United States $3.499B 0.00
Immunomedics (IMMU) United States $3.427B 0.00
Blueprint Medicines (BPMC) United States $3.348B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.301B 0.00
Zai Lab (ZLAB) China $3.256B 0.00
Genmab (GMAB) Denmark $3.175B 12.45
Emergent Biosolutions (EBS) United States $3.172B 22.18
CRISPR Therapeutics AG (CRSP) Switzerland $3.162B 53.57
NeoGenomics (NEO) United States $3.161B 168.22
Momenta Pharmaceuticals (MNTA) United States $3.156B 0.00
Halozyme Therapeutics (HALO) United States $3.140B 0.00
Alkermes (ALKS) Ireland $3.119B 247.13
Intercept Pharmaceuticals (ICPT) United States $2.975B 0.00
MyoKardia (MYOK) United States $2.952B 0.00
Insmed (INSM) United States $2.667B 0.00
Amicus Therapeutics (FOLD) United States $2.650B 0.00
UniQure (QURE) Netherlands $2.546B 0.00
Arena Pharmaceuticals (ARNA) United States $2.469B 5.74
Fate Therapeutics (FATE) United States $2.318B 0.00
RA PHARMCTL INC (RARX) United States $2.197B 0.00
Denali Therapeutics (DNLI) United States $2.179B 0.00
Principia Biopharma (PRNB) United States $2.064B 0.00
Epizyme (EPZM) United States $1.971B 0.00
Alector (ALEC) United States $1.885B 0.00
REGENXBIO (RGNX) United States $1.850B 0.00
Ligand Pharmaceuticals (LGND) United States $1.758B 51.32
Arvinas (ARVN) United States $1.686B 0.00
Zymeworks (ZYME) Canada $1.634B 0.00
Akcea Therapeutics (AKCA) United States $1.577B 0.00
Coherus BioSciences (CHRS) United States $1.520B 0.00
Zealand Pharma (ZEAL) Denmark $1.414B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.399B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.399B 0.00
Myriad Genetics (MYGN) United States $1.393B 24.58
Intra-Cellular Therapies (ITCI) United States $1.275B 0.00
Editas Medicine (EDIT) United States $1.215B 0.00
Revance Therapeutics (RVNC) United States $1.214B 0.00
Twist Bioscience (TWST) United States $1.171B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.158B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.065B 0.00
Athenex (ATNX) United States $1.057B 0.00
PHARMA MAR SA (PHMMF) Spain $0.938B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Adverum Biotechnologies (ADVM) United States $0.888B 0.00
DBV Technologies S.A (DBVT) France $0.877B 0.00
Cytokineticsorporated (CYTK) United States $0.869B 0.00
Vericel (VCEL) United States $0.844B 314.83
Mesoblast (MESO) Australia $0.843B 0.00
Sangamo Therapeutics (SGMO) United States $0.820B 0.00
Codexis (CDXS) United States $0.791B 0.00
Arcus Biosciences (RCUS) United States $0.754B 0.00
Intrexon (PGEN) United States $0.745B 0.00
Heska (HSKA) United States $0.743B 189.82
Cellectis S.A (CLLS) France $0.723B 0.00
Retrophin (RTRX) United States $0.711B 0.00
ANI Pharmaceuticals (ANIP) United States $0.710B 12.11
Cara Therapeutics (CARA) United States $0.655B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
GENFIT S.A (GNFT) France $0.637B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.627B 5.27
Intellia Therapeutics (NTLA) United States $0.615B 0.00
UROGEN PHARMA (URGN) United States $0.613B 0.00
Anika Therapeutics (ANIK) United States $0.608B 20.78
Cel-Sci (CVM) United States $0.608B 0.00
Kadmon Holdings (KDMN) United States $0.595B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.563B 0.00
Bellus Health (BLU) Canada $0.552B 0.00
Clovis Oncology (CLVS) United States $0.544B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
AC Immune SA (ACIU) Switzerland $0.532B 12.30
NantKwest (NK) United States $0.531B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.491B 0.00
Puma Biotechnology (PBYI) United States $0.489B 0.00
Prothena (PRTA) Ireland $0.486B 0.00
BioDelivery Sciences (BDSI) United States $0.470B 0.00
Compugen (CGEN) Israel $0.468B 0.00
Agenus (AGEN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mersana Therapeutics (MRSN) United States $0.432B 0.00
Cue Biopharma (CUE) United States $0.428B 0.00
AnaptysBio (ANAB) United States $0.427B 0.00
Precision BioSciences (DTIL) United States $0.418B 0.00
Merus (MRUS) Netherlands $0.406B 0.00
Pfenex (PFNX) United States $0.403B 0.00
Inovio Pharmaceuticals (INO) United States $0.401B 0.00
Sorrento Therapeutics (SRNE) United States $0.401B 0.00
Kindred Biosciences (KIN) United States $0.401B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.398B 0.00
Dynavax Technologies (DVAX) United States $0.397B 0.00
PDL BioPharma (PDLI) United States $0.392B 9.81
Avid Bioservices (CDMO) United States $0.389B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.375B 0.00
Stemline Therapeutics (STML) United States $0.333B 0.00
Gritstone Oncology (GRTS) United States $0.330B 0.00
CytomX Therapeutics (CTMX) United States $0.329B 0.00
Cellular Biomedicine (CBMG) United States $0.325B 0.00
MannKind (MNKD) United States $0.314B 0.00
Albireo Pharma (ALBO) United States $0.311B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.300B 0.00
Aduro Biotech (ADRO) United States $0.300B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.294B 2.04
Starpharma Holdings (SPHRY) Australia $0.289B 0.00
OSMOTICA PHARM (OSMT) United States $0.288B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.285B 0.00
Syros Pharmaceuticals (SYRS) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.282B 0.00
Kamada (KMDA) Israel $0.262B 10.91
Novavax (NVAX) United States $0.262B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.259B 0.00
Sutro Biopharma (STRO) United States $0.253B 0.00
VBI Vaccines (VBIV) United States $0.253B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Protagonist Therapeutics (PTGX) United States $0.242B 0.00
Geron (GERN) United States $0.240B 0.00
IVERIC Bio (ISEE) United States $0.237B 0.00
Kala Pharmaceuticals (KALA) United States $0.233B 0.00
ChromaDex (CDXC) United States $0.229B 0.00
XOMA (XOMA) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Prometic Life Sciences (LMNL) Canada $0.220B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.216B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
TELA Bio (TELA) United States $0.209B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.208B 10.69
Alcobra (ARCT) United States $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.200B 0.00
Abeona Therapeutics (ABEO) United States $0.200B 0.00
Athersys (ATHX) United States $0.196B 0.00
Cerecor (CERC) United States $0.192B 0.00
Five Prime Therapeutics (FPRX) United States $0.191B 0.00
Affimed (AFMD) Germany $0.191B 0.00
Theratechnologies (THTX) Canada $0.189B 0.00
Arbutus Biopharma (ABUS) Canada $0.188B 0.00
VolitionRX (VNRX) Singapore $0.187B 0.00
VTv Therapeutics (VTVT) United States $0.186B 0.00
Exicure (XCUR) United States $0.182B 0.00
Fortress Biotech (FBIO) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
Strongbridge Biopharma (SBBP) United States $0.166B 4.45
Northwest Biotherapeutics (NWBO) United States $0.160B 0.00
Selecta Biosciences (SELB) United States $0.159B 0.00
Windtree Therapeutics (WINT) United States $0.158B 0.00
CorMedix Inc (CRMD) United States $0.156B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.154B 0.00
Verastem (VSTM) United States $0.153B 0.00
Aptinyx (APTX) United States $0.149B 0.00
Dyadic (DYAI) United States $0.144B 0.00
Liquidia Technologies (LQDA) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Arsanis (XFOR) United States $0.133B 0.00
ARAVIVE, INC (ARAV) United States $0.132B 0.00
Palatin Technologies (PTN) United States $0.131B 3.57
Antibe Therapeutics (ATBPF) Canada $0.128B 0.00
OvaScience (MLND) United States $0.127B 0.00
Menlo Therapeutics (MNLO) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Clearside Biomedical (CLSD) United States $0.112B 0.00
Prima BioMed (IMMP) Australia $0.112B 0.00
AIT Therapeutics (XAIR) United States $0.105B 0.00
Happiness Biotech Group (HAPP) China $0.105B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Vaccinex (VCNX) United States $0.104B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.102B 0.00
Proteostasis Therapeutics (PTI) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.093B 0.00
Applied Genetic Technologies (AGTC) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Catalyst Biosciences (CBIO) United States $0.077B 0.00
Pluristem Therapeutics (PSTI) Israel $0.074B 0.00
Orgenesis (ORGS) United States $0.072B 4.63
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Trevena (TRVN) United States $0.068B 0.00
Acorda Therapeutics (ACOR) United States $0.066B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Advaxis (ADXS) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
TOCAGEN INC (TOCA) United States $0.050B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
Celldex Therapeutics (CLDX) United States $0.046B 0.00
Curis (CRIS) United States $0.045B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
AquaBounty Technologies (AQB) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
Celsion (CLSN) United States $0.029B 0.00
Pulmatrix (PULM) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Oncobiologics (OTLK) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
VIVUS (VVUS) United States $0.025B 0.00
IBio (IBIO) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.021B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.015B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.015B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.004B 0.00